European Urology
European Urology is the European Association of Urology's journal and the most cited urology title, publishing prostate, bladder and kidney cancer trials, the EAU guidelines and PSMA imaging studies.
Overview
Publishes the EAU guidelines, prostate-cancer screening and active-surveillance cohorts, PSMA PET and radioligand studies, and secondary analyses of the large phase 3 trials in bladder and kidney cancer. Hybrid access via Elsevier; sister titles include European Urology Oncology and European Urology Open Science.
Urologist who co-led proPSMA, the trial that showed PSMA PET should replace CT and bone scan for staging prostate cancer.
Nuclear medicine physician who leads ENZA-p and the PSMA imaging trials shaping Australian theranostics.
Peter Bartenstein is a nuclear medicine head whose department is a leading European PSMA theranostics centre.
A cancer doctor at Weill Cornell in New York who has spent two decades testing PSMA-targeted radioactive treatments for prostate cancer, from the first antibody versions through to lutetium-177 PSMA-617.
Founder and chair of the APCCC consensus conference that guides advanced prostate cancer management worldwide.
Similar pages
not linked directly; found by shared links- TrialSTAMPEDE
Shares Silke Gillessen, Prostate cancer.
- TrialproPSMA
Shares Declan G. Murphy, Prostate cancer.
- InstitutionANZUP Cancer Trials Group
Shares Declan G. Murphy, Prostate cancer.
- InstitutionPeter MacCallum Cancer Centre
Shares Declan G. Murphy, Prostate cancer.